Doman Group’s GSK GSK Stock Holding History

Doman Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$2.11M	Buy	+38,214	New	+$1.99M	1.85%	19

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Doman Group's GSK Position: Q4 2021 in Review

Doman Group opened a new position in GSK (GSK) in Q4 2021: 38,214 shares worth $2.11M. The stake represents 1.85% of the portfolio and ranks #19 among its holdings.

919 funds tracked by Wall St. Rank hold GSK as of Q4 2021.

Doman Group held 38,214 shares of GSK worth $2.11M as of Q4 2021.
GSK was a new Doman Group position in Q4 2021.
GSK made up 1.85% of Doman Group's portfolio in Q4 2021, its #19 holding.
919 funds tracked by Wall St. Rank held GSK as of Q4 2021.

Based on Doman Group's 13F filing for Q4 2021, filed 14 Mar 2022.